Home - Products - Others - Other Targets - Physcion-8-O-β-gentiobioside

Physcion-8-O-β-gentiobioside

CAS No. 84268-38-2

Physcion-8-O-β-gentiobioside( ——— )

Catalog No. M38240 CAS No. 84268-38-2

Physcion-8-O-β-gentiobioside is an anthraquinone glycoside isolated from rhubarb roots.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG Get Quote Get Quote
50MG Get Quote Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Physcion-8-O-β-gentiobioside
  • Note
    Research use only, not for human use.
  • Brief Description
    Physcion-8-O-β-gentiobioside is an anthraquinone glycoside isolated from rhubarb roots.
  • Description
    Physcion-8-O-β-gentiobioside is an anthraquinone glycoside isolated from rhubarb roots.
  • In Vitro
    ———
  • In Vivo
    ———
  • Synonyms
    ———
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ———
  • Research Area
    ———
  • Indication
    ———

Chemical Information

  • CAS Number
    84268-38-2
  • Formula Weight
    608.54
  • Molecular Formula
    C28H32O15
  • Purity
    >98% (HPLC)
  • Solubility
    ———
  • SMILES
    ———
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Holzschuh, Liselotte, et al. Physcion-8-O-β-D-gentiobiosid, ein neues Hauptglykosid aus Radix Rhei. Planta Medica, 46(11), 159–161.
molnova catalog
related products
  • THK5351

    THK5351 is a tracer involved in PET imaging for electron emission tomography imaging of Alzheimer's disease and cognitive impairment.

  • [pThr3]-CDK5 Substra...

    [pThr3]-CDK5 Substrate TFA is an effective Phospho-Thr3CDK5 Substrate. [pThr3]-CDK5 Substrate is phosphorylated by CDK5 with a Km value of 6 μM.

  • 1-Deoxymannojirimyci...

    1-Deoxymannojirimycin hydrochloride is a selective α1,2-mannosidase inhibitor(IC50: 20 μM). 1-Deoxymannojirimycin hydrochloride also inhibits HIV‐1 strains and has poor antiviral activity.